Johnson & Johnson (JNJ)

Exchange
NYSE
Symbol
JNJ
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.
Country
USA

Stock price

At close: October 4, 2024

  • Open
    159.63
  • High
    160.50
  • Low
    158.78
  • Close
    160.29
  • Volume
    5,331,690

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
3.93
Receivables turnover
5.96
Payables turnover
4.56
Working capital turnover
12.29
Days of inventory on hand (DOH)
92.91
Days of sales outstanding (DSO)
61.25
Number of days of payables
80.04
Fixed asset turnover
4.45
Total asset turnover
0.53
 Liquidity ratios
Current ratio
1.16
Quick ratio
0.91
Cash ratio
0.59
Cash conversion cycle
74.12
 Solvency ratios
Debt-to-assets ratio
0.15
Debt-to-capital ratio
0.27
Debt-to-equity ratio
0.38
Financial leverage ratio
2.44
Interest coverage
42.71
 Profitability ratios
Gross profit margin
66.12%
Operating profit margin
27.21%
Pretax margin
42.54%
Net profit margin
39.66%
Operating return on assets (Operating ROA)
14.39%
Return on assets (ROA)
20.98%
Return on total capital
40.79%
Return on equity (ROE)
51.11%